Previous Close | 25.44 |
1-Year Change | -14.23% |
6-Months Change | 96.6% |
3-Months Change | 52.88% |
Moving Avg (50d) | 21.891 |
Moving Avg (200d) | 20.74 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.18B |
Beta (3-Years) | 0.7 |
Revenue Growth (ttm) | 1.78% |
Net Profit Margin (ttm) | 1.05% |
Return On Assets (ttm) | 0.46% |
EPS (ttm) | 0.09 |
PE Ratio (ttm) | 282.67 |
Dividend Yield | % |
Asset Description: | Pacira BioSciences, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-02-14 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
25.949 | 26.712 | 27.221 | 27.984 | 29.256 | 30.528 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |